Neutrophil-to-lymphocyte Ratio As a Detection Marker of Tumor Recurrence in Patients with Muscle-invasive Bladder Cancer After Radical Cystectomy
Overview
Authors
Affiliations
Purpose: High-neutrophil to lymphocyte ratio (NLR) values have been shown to be associated with a poor prognosis in many human malignant tumors. We evaluated the correlation of the NLR with other variables in patients with muscle-invasive bladder cancer after radical cystectomy (RC); in particular, we evaluated chronological changes in the postoperative NLR.
Methods: We included the data from a total of 110 patients who underwent RC for muscle-invasive bladder cancer. The NLR was calculated using complete blood counts determined before RC. Kaplan-Meier and Cox proportional regression analyses of recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were performed to identify significant prognostic variables.
Results: The median patient age was 72 years (41-91 years). In univariate analysis, the pretreatment NLR (≥2.6 vs.<2.6) was associated with RFS (hazard ratio [HR] = 2.41, P = 0.008), CSS (HR = 2.89, P = 0.006), and OS (HR = 2.73, P = 0.002). In multivariate analysis, an NLR≥2.6 and an infiltrative growth pattern at the tumor invasion front were significantly associated with RFS (HR = 2.61, P = 0.023), CSS (HR = 2.58, P = 0.08), and OS (HR = 2.77, P = 0.004). Postoperative chronological analysis revealed that the NLR of 68 patients without recurrence remained low during follow-up, whereas the NLR of the remaining 42 patients with recurrence increased significantly in the last visit before recurrence was detected radiographically (P< 0.01).
Conclusions: The NLR and tumor growth pattern were strong predictors of prognosis for patients undergoing RC. Our results suggest that an increase in the NLR during follow-up after RC is a potential marker for the early detection of recurrence.
Chen Z, Zhang Y, Chen T Front Oncol. 2024; 14:1463173.
PMID: 39507758 PMC: 11540557. DOI: 10.3389/fonc.2024.1463173.
Iemura Y, Miyake M, Fukui S, Fujii T, Ohnishi S, Hori S Curr Urol. 2023; 17(4):229-235.
PMID: 37994338 PMC: 10662802. DOI: 10.1097/CU9.0000000000000193.
Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer.
Miyake M, Nishimura N, Ohnishi S, Oda Y, Owari T, Ohnishi K Cancers (Basel). 2023; 15(9).
PMID: 37174031 PMC: 10177453. DOI: 10.3390/cancers15092565.
Ofner H, Laukhtina E, Hassler M, Shariat S Int J Mol Sci. 2023; 24(6).
PMID: 36982918 PMC: 10056816. DOI: 10.3390/ijms24065846.
Ni Z, Wu B, Liu Z, Wang Q, Han X, Cheng W Br J Radiol. 2023; 96(1145):20220887.
PMID: 36715151 PMC: 10161921. DOI: 10.1259/bjr.20220887.